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Abstract 
Background: Cardiovascular disease (CVD) has become a leading cause of 
death and disability in Thailand due to the unhealthy lifestyle of the populace; 
triggering high risk of exposure to CVD, and increased the number of hospi-
tal admissions year on year. Objectives: The concerns generated by the infla-
tion in the health care expenditure among service providers motivated this 
study to examine the costs of hospitalisation of inpatients with (CVD) condi-
tions in Thailand, 2009. Methods: Anonymised secondary data of 327,435 
CVD inpatients under “Universal Coverage” (UC) health care scheme were 
obtained from the National Health Security Office (NHSO), Thailand. The 
data (51.69% women and 48.31% men) were classified using International 
Classification of Diseases, Tenth Revision (ICD-10) code, of which I20 - I25 
are Ischemic heart disease (IHD), I60 - I69 are stroke and I00 - I99 are all 
CVD conditions. Results: Average costs of treatments for all CVD conditions, 
IHD and stroke were ฿21,921 (£1 = ฿50), ฿32,884 (highest) and ฿25617.67 per 
patient respectively. Absolute total cost increased with age and the cost of ad-
mission of male patients is higher than female. The average (three months) 
length of stay for stroke patients was found to be the highest. Conclusion: Pro-
viders generally spent a total of ฿7177 million on the treatment of CVD with 
IHD and stroke taking ฿2544 million and ฿1920 million respectively. 
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1. Introduction 
Over the past decade, CVD has been one of the leading causes of premature 
death and disability and has become a burden in Thailand [1]. As a result of 
Thailand’s urbanisation the peoples’ lifestyles have changed, such as a decrease 
in the level of physical activities, changing their dietary patterns and habits 
which increase metabolic risk factors such as BMI, total cholesterol and blood 
pressure [2] [3] [4] [5] [6]. 
The National Health Security Office, Thailand reported that the number of 
hospital admissions which are caused by CVD conditions has continuously in-
creased and has tripled since 1992 [7]. This has not only increased the number of 
the hospital admissions but has also affected the loss of productivity due to ab-
sence from work, a decline in the quality of life and increased health care expen-
diture, of both health care services providers and the patients’ families. In 2007, 
Thailand spent $36.5 million on inpatients medical care for non-communicable 
diseases, of which 10% of this expenditure was attributable to CVD [8]. 
There were several studies on the health care cost of CVD in Thailand. In 
2007, the median cost of treatment for acute coronary syndrome (ACS) patients 
was ฿47,908 (£1 = ฿50). However, the cost of treatment varied depending on the 
diagnosis group, treatment procedures and the complication of the diseases [9]. 
The annual hospital charges for the treatment of multiple chronic conditions 
varied from ฿611 to ฿16,794, depending on the health status and severity of the 
disease in the patient [10]. Some studies estimated the medical costs attributable to 
risk factors such as cigarette smoking and obesity. The average direct out-of-pocket 
cost of CHD which was attributable to smoking was estimated at ฿33716.40 per 
patient or ฿1773.68 million in total [11]. The total economic cost attributable to 
obesity has been estimated at ฿2168.4 million spending on IHD and ฿2017.6 
million spending on stroke, which includes health care costs, cost of premature 
death and the cost of productivity loss due to hospital-related absenteeism [12].  
Regarding the cost of stroke rehabilitation, it was found that stroke patients 
spent, on average ฿11170.56 ± 5641.73 per patient at the medical rehabilitation 
[13]. Additionally, out of pocket expenses of stroke patients occur when they 
need informal care, which is usually provided by their family, friends or 
neighbours. The cost of informal care for stroke patients has been estimated at 
฿4642.6 per month, based on 2006 prices.  
The average time spent on the national care of stroke patients was 94.6 hours, 
which implies that there is a loss of opportunity costs which are forgone because 
unpaid work was undertaken in caring for the patient [14]. Although it is already 
known that CVD has become an economic burden in Thailand, there were limited 
studies focused on how to tackle this issue. This study, however, aimed to investi-
gate the national level of the total cost of CVD for Thailand during 2009.  
2. Methods 
This is a prevalence-based study of the health care expenditure of CVD in-patients 
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in Thailand, 2009. In this study, CVD is defined according to the international 
classification of diseases 10th version (ICD-10) [15]. The CVD conditions have 
been classified and analysed by the ICD-10 codes of which I20 to I25 refers to 
ischemic heart diseases, I60 to I69 refer to stroke and I00 to I99 relate to all CVD 
conditions. 
2.1. Data Sources 
The health care costs of CVD have been analysed using data from the inpatient’s 
services in Thailand in 2009-2010. The numbers and the costs of the anonymous 
inpatient data were obtained from the National Health Security Office (NSO) 
[7], Thailand. This data includes the inpatient hospital admissions in the Uni-
versal Coverage Health Care Scheme (UC), which is the primary health care in-
surance system in Thailand. Approximately 47.24 million of the population or 
75.29% of the total population of 64 million are in the UC scheme. The health 
care services cover 11,460 health care units nationwide, which include public 
hospitals managed under the ministry of public health, other public hospitals, 
private hospitals and sub-district health promoting hospitals. 
2.2. Data Collection 
The number of hospital admissions and the cost of hospitalisation were obtained 
from the National Health Security Office (NHSO), Thailand [7]. A formal letter, 
research protocol, dummy tables, plans for data analysis and the data requested 
form were submitted to the NHSO during September 2013. The data permission 
was approved in May 2014. The use of the anonymous hospitalisation data is 
controlled under the criteria of the data sharing policy from NHSO, Thailand.  
Data verification and preparation: The ICD-10 code has classified the anony-
mous CVD inpatients data. A descriptive analysis of all variables in the data set 
has been performed to look at data coding, frequency and the distribution of 
data. If the total cost, the length of stay and the average cost per day is inconsis-
tent, those records will be recorded as missing. The continuous variables such as 
the length of stay and total costs have been checked for the outlier values. The 
outliers of the total cost of hospitalisation data have been identified by calculat-
ing the cost of hospital admissions per day. The minimum cost of hospital ad-
mission was set at ฿500 per day (£10 per day) [7], which was the minimum 
amount a patient usually pay at the point of admission into a public hospital. 
The maximum cost of hospital admission was up to ฿65,000 per day (£1300 per 
day), which was the maximum possible cost if the patients received a specialist 
medical procedure or were admitted to an intensive care unit (ICU).  
2.3. Health Care Cost 
The focus of this study is basically on the health care service providers’ perspec-
tive. The total cost of treatment and hospitalisation included both direct medical 
cost and direct non-medical cost such as; room rates and meals, the prosthesis, 
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medical devices used in treatment, medication that was used in hospitals, the 
medical diagnosis, the clinical resources, therapeutic radiology, medical equip-
ment, medical procedure fees, nursing services, physical and rehabilitation ser-
vices in hospital, other specialist diagnostic methods, and the other treatments 
from health professionals. However, since the patients’ perspectives are not con-
sidered in this study, the indirect costs such as the cost of productivity loss due 
to absence from work, costs on patients and their family out of pocket expenses 
are not included in the analysis.  
2.4. Statistical Analysis 
The descriptive statistics present the overall health care costs of CVD, in mean 
and absolute total costs of hospital admissions.The unit of hospitalisation cost 
will be presented in Thai Baht (£1 = ฿50). The total cost of hospital admissions 
will be calculated by multiplying the number of CVD patients by the average 
cost of hospital admission per patient. The statistical analysis has been carried 
out using a STATA software version 14 [16]. 
Ethical approval: This study has used secondary data and this why ethical 
approval was not needed. However, Health Care organisation in Thailand has 
allowed us to access these datasets (the hospitalisation data from the social secu-
rity health insurance system, and the civil servant health insurance system). 
3. Results 
Table 1 shows the number and percentage of the 327,435 patients who had a 
primary diagnosis with CVD conditions (ICD-10, I00 - I99), classified by CVD 
condition, age group, gender, length of stay and the discharge status.  
Of the 327,345 patients, 23.6% had Ischemic heart disease (IHD), 22.9% had a 
stroke, and 53.5% had other CVD conditions. The number of CVD inpatients 
increased respectively by age groups but slightly decreased at age 75 years and 
over. The number of IHD and stroke patients was high in the middle and elderly 
age groups, with the number of patients increasing at age 45 - 54 years and reach 
the highest at age 65 - 74 years. Although the number of CVD inpatients in the 
younger age groups 15 - 24 years and 25 - 34 years was lower than in the older 
age groups, the proportion of patients who had other CVD conditions was 
higher than the older age groups. The results show that at age 15 - 24 years, of 
4706 patients, 3.1% had IHD, 12.8% had a stroke and 84.2% had other CVD 
conditions. While at age 55 - 64 years, of 74,073 patients, half of them had IHD 
and stroke and half of them had the other CVD conditions.  
When comparing between genders, the number of inpatients with IHD and 
stroke in men was higher than in women. Conversely, the number of patients 
with other CVD conditions was higher in women than in men. However, overall 
more women were admitted to the hospital with CVD conditions than men.  
When classifying patients by the length of stay, patients with CVD a condition 
were mostly admitted to hospital for less than one month. 24% of patients in this  
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Table 1. Number and percentage of CVD patients classified by CVD conditions, Univer-
sal Coverage Health Care Scheme (UC), Thailand 2009. 
Categories IHD Stroke Other CVD All CVD 
Age     
15 - 24 146 (3.1%) 600 (12.8%) 3960 (84.2%) 4706 (100%) 
25 - 34 614 (7.3%) 1266 (15%) 6549 (77.7%) 8429 (100%) 
35 - 44 3483 (14.2%) 4774 (19.4%) 16,337 (66.4%) 24,594 (100%) 
45 - 54 10,997 (20.9%) 12,211 (23.3%) 29,317 (55.8%) 52,525 (100%) 
55 - 64 19,945 (26.9%) 16,902 (22.8%) 37,226 (50.3%) 74,073 (100%) 
65 - 74 23,894 (27.6%) 20,129 (23.3%) 42,475 (49.1%) 86,498 (100%) 
≥75 18,314 (23.9%) 19,067 (24.9%) 39,299 (51.2%) 76,610 (100%) 
Gender     
Men 42,692 (27%) 40,736 (26%) 74,768 (47%) 158,196 (100%) 
Women 34,701 (21%) 32,213 (20%) 100,325 (59%) 169,239 (100%) 
Lengths of stay     
<1month 76,720 (24%) 72,289 (22%) 173,487 (54%) 322,496 (100%) 
≥1 - 3 months 646 (15%) 2290 (52%) 1502 (34%) 4438 (100%) 
≥3 - 6 months 22 (6%) 281 (71%) 92 (23%) 395 (100%) 
≥6 - 9 months 1 (1.6%) 56 (84.9%) 9 (13.6%) 66 (100%) 
≥9 - 12 months 2 (15.4%) 9 (69.2%) 2 (15.4%) 13 (100%) 
Unspecified 2 (7.4%) 24 (88.9%) 1 (3.7%) 27 (100%) 
Discharge status     
Complete recovery 247 (21.2%) 154 (13.2%) 762 (65.5%) 1163 (100%) 
Improve 4988 (23.7%) 4949 (20.1%) 153,859 (56.2%) 273,787 (100%) 
Not improve 7162 (23.1%) 10,492 (33.9%) 131,315 (42.9%) 30,969 (100%) 
Died 4969 (23.2%) 9340 (43.7%) 7090 (33.1%) 21,399 (100%) 
Unspecified 27 (23.1%) 23 (19.7%) 67 (57.3%) 117 (100%) 
Total 77,393 (23.6%) 74,949 (22.9%) 175,093 (53.5%) 327,435 (100%) 
 
group were admitted with IHD, 22% admitted with stroke and 54% admitted 
with other CVD conditions. However, there were 4438 in patients who were 
admitted between 1 to 3 months, 52% of them admitted with a stroke, 15% ad-
mitted with IHD and 34% admitted with other CVD conditions. Additionally, 
patients who were admitted to the hospital for more than three months were 
mostly stroke patients.  
For the discharge status, 273,787 patients had improved from their illness 
when discharged from the hospital. 23.7% of them improved from IHD, 20.1% 
improved from stroke and 56.2% improved from the other CVD conditions. 
1163 patients had complete recovery after being admitted to the hospital of 
which 21.2% recovered from IHD, 13.2% of them recovered from a stroke and 
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65.5% recovered from the other CVD conditions. However, 30,969 patients did 
not improve from their illness, and 21,399 patients were discharged because they 
died in hospital.  
Table  2 shows the absolute total cost of hospital admissions by categories and 
CVD conditions. Overall, CVD patients cost ฿7199 million (£143 million) of 
which IHD patients cost ฿2531 million (£50 million), stroke patients cost ฿1907 
million (£38 million), and the other CVD conditions cost ฿2680 million (£53 
million). The absolute total cost increased with each increasing age group but 
slightly decreased at the age of 75 years and over. When compared between 
genders, male patients had an absolute total cost of hospital admission more 
than women, which was ฿3888 million (£77 million) in men and ฿3231 million 
(£64 million) in women. The health care costs of treating men with IHD and 
stroke are higher than women. Conversely, the costs of treating women with  
 
Table 2. Absolute Total Cost of Hospital Admission by Categories and CVD Condition 
(THB (฿)*). 
Categories IHD Stroke Other CVD All CVD 
Age groups     
15 - 24 2,257,119 27,325,711 79,120,065 108,702,894 
25 - 34 14,390,400 37,450,052 127,964,733 179,805,186 
35 - 44 108,533,174 141,845,311 319,239,325 569,617,811 
45 - 54 380,368,138 325,286,934 532,507,274 1,238,162,346 
55 - 64 744,748,695 419,013,435 579,576,458 1,743,338,588 
65 - 74 814,269,234 489,638,746 582,287,556 1,886,195,536 
75+ 466,645,916 466,828,809 460,208,145 1,393,682,870 
Gender     
Men 1,532,931,439 1,038,994,870 1,316,312,781 3,888,239,089 
Women 998,281,238 868,394,128 1,364,590,777 3,231,266,142 
Length of stay     
<1 month 2,353,265,367 1,261,968,543 2,328,073,213 5,943,307,123 
≥1 - 3 months 159,254,375 462,529,711 297,183,150 918,967,236 
≥3 - 6 months 15,696,554 129,767,646 44,386,186 189,850,386 
≥6 - 9 months 573,153 28,518,983 9,063,731 38,155,866 
≥9 - 12 months 1,883,622 6,503,539 1,716,157 10,103,318 
Discharge status     
Complete recovery 8,020,575 3,389,411 17,132,857 28,542,843 
Improve 2,215,026,299 1,268,554,308 2,227,019,320 5,710,599,928 
Not improve 77,724,478 164,419,209 134,613,690 376,757,378 
Died 229,479,019 470,848,354 301,279,921 1,001,607,294 
Total 2,531,212,676 1,907,388,998 2,680,903,557 7,119,505,231 
*Note: (£1 = ฿50). 
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other CVD conditions are higher than those spent on men. The graph which 
compares the absolute total costs by age groups, gender and CVD conditions is 
presented in Figure 1 and Figure 2. Concerning the length of stay, the absolute 
total health care cost was highest in patients who were admitted to the hospital 
for less than one month because the number of patients in this group was higher 
than the other groups. The total cost spent on patients who had IHD and were 
admitted to the hospital for less than one month was ฿2353 million (£47 mil-
lion). Patients with stroke and admitted to the hospital for less than one month 
cost ฿1261 million (£25 million). Additionally, patients with other CVD condi-
tions cost as much as IHD patients, which was ฿2328 million (£46 million). 
Furthermore, patients who were admitted between 9 to 12 months had a higher 
absolute total cost than patients who were admitted between 1 and up to 9 months.  
When classified by the discharge status, the highest absolute health care cost 
was in patients who improve from illness, which cost ฿5710 million (£114 mil-
lion) in total, of which ฿2215 million (£44 million) was spent on IHD patients, 
and ฿1268 million (£25 million) spent on stroke patients, and ฿2227 million 
(£44 million) spent on other CVD patients. However, the total cost of hospital 
admissions was higher in patients who died from CVD. Some other studies that 
focused on other countries in Asia came up with different figures [17] [18] [19] 
[20] [21]. Table  3 shows a summary of the total cost of hospitalisation by CVD 
conditions in 2009. There were 327,435 CVD patients admitted to the hospital 
under the UC health care scheme. 77,393 patients were admitted for IHD, 74,949 
patients were admitted for stroke, and 175,093 patients were admitted for the 
other CVD conditions.  
The average length of stay was highest in stroke patients which were 6.72 days, 
IHD patients stayed in hospital on average 4.12 days, while patients who had 
other CVD conditions stayed in hospital on average 3.99 days. The average cost 
per day was highest in IHD patients, which cost ฿10,681 per day and second 
highest in stroke patients which cost ฿4067 per day, while the other CVD condi-
tions cost ฿3614 per day. 
The average cost per patients was highest in IHD patients, stroke and other 
CVD respectively. IHD patients cost on average ฿32,884, stroke patients cost on 
average ฿25,617, and the other CVD patients cost on average ฿15,465. 
 
Table 3. Summary of the total cost of hospitalisation by CVD conditions in 2009. 
CVD Conditions Total number of cases 
The average length of 
stay (days) 
Average cost per day 
(THB*) 
Average cost per 
patient (THB*) 
Total cost (THB*) 
= (number of cases ×  
average cost per patients) 
IHD (I20 - I25) 77,393 4.12 10,681 32,884 2,544,991,412 
Stroke (I60 - I69) 74,949 6.72 4067 25,617 1,920,018,748 
other CVD 175,093 3.99 3614 15,465 2,707,858,769 
All CVD (I00 - I99) 327,435 4.65 5393 21,921 7,177,705,909 
*Note: (£1 = ฿50). 
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Figure 1. The absolute total cost of hospital admission by gender and CVD conditions, 
Thailand 2009 (THB). 
 
 
Figure 2. The absolute total cost of hospital admission by age group gender and CVD 
condition. 
 
The total cost of the IHD was ฿2544 million, and the total cost of stroke was 
฿1920 million. The total cost of the other CVD conditions was ฿2707 million, 
which was higher than IHD and stroke.  
Overall, the CVD patients admitted to the hospital stayed on average 4.65 
days, the average cost per day was ฿5393, and the average cost per patients was 
฿21,921. The health service providers spent in the total of ฿7177 million on the 
treatment of CVD.  
4. Discussion 
4.1. Findings  
Although this analysis was focused only on patients covered under the UC 
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health care scheme, it covered the majority (75.29%) of the total population. The 
other health care schemes that were not included in the analysis were the Social 
Security (SS) health care scheme, which covered 15.42% of the population and 
the Civil Servant (CS) health care scheme which covers 8.2% of the population. 
Another limitation is that it covers mainly public hospitals, as only 60 private 
hospitals had been enrolled in the UC health care scheme. Therefore, the cost of 
hospital admission for CVD may underestimate the cost of hospital admission in 
a private hospital because the cost of treatment in a private hospital may be more 
expensive 
Considering the health care costs by age groups, the absolute total health care 
cost was higher in the middle to elderly age groups because the number of cases 
was higher than younger age groups. Although the younger age groups had low-
er numbers of hospital admissions, when exploring the primary diagnosis of 15 
to 24 years age group, it was found that majority of patients at age 15 to 24 had 
been diagnosed with other CVD conditions such as arthritis, heart failure, hypo-
tension, endocarditis etc.  
Hence, 1.44% of CVD inpatients were in this age group. When comparing the 
health care cost by discharge status, it was found that patients who died from 
CVD had the highest expenditure compared to those who completely recovered 
and those who did not recover or improve. This was because the patients who 
died were more likely to have stayed in the hospital longer than patients in the 
other groups.  
When investigating the average length of stay by discharge status, it was found 
that patients who died from CVD had an average length of stay 7.23 days.  
While patients who improved from CVD after admission to hospital stayed on 
average 4.6 days and patients who completely recovered from CVD stayed on 
average 4.05 days. On the other hand, patients who did not improve from CVD 
stayed on an average of 3 days. 
Although the average cost per patients in the other CVD conditions is lower 
than IHD and stroke, the total cost of other CVD conditions was at the highest 
at ฿2707 million, because the number of total cases in this group is higher than 
IHD and stroke. However, IHD and stroke have a higher cost per patient.  
4.2. What Is Already Known on This Topic and What This Study  
Adds? 
Although it is already known that CVD has become an economic burden in 
Thailand and other Asian countries [22]-[27], the studies on the costs of hospital 
admissions are not up to date and are mostly limited to single health care units 
or individual groups. To the best of the author’s knowledge, this is the first study 
that focused on healthcare and hospitalisation costs of CVD, IHD, and Stroke in 
Thailand. The benefit of this analysis is the capability to estimate the future oc-
currence of CVD events and the associated costs based on the currently available 
information and the scientific evidence, instead of following-up people over a 
long period. 
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This study provides the information for the health policy developers to plan 
and invest in primary prevention programs for chronic diseases such as CVD, 
IHD, and Stroke rather than waiting until the problems occur or the prevalence 
of CVD increases in the population.  
4.3. Limitations 
This analysis focused only on the total expenditure that occurred when patients 
were admitted to the hospital. So, it was only from a health service provider 
perspective. There may have been hidden costs occurring when the patients were 
discharged from the hospital. They may have needed long-term care and reha-
bilitation. The patients and their families might have incurred some out of pock-
et costs such as the productivity loss, time lost due to work absenteeism, did not 
form part of this study because there were limitations in accessing the data. Fur-
thermore, there was a limitation of the dataset which did not provide the infor-
mation on the type of medical procedures that had been used for treatment, 
which may affect the cost of hospitalisation when patients required specialist 
treatments.  
5. Conclusion 
In conclusion, this study found that CVD had a significant impact on the hospi-
talization costs and economic burden in Thailand. In 2009, the health service 
providers spent ฿7177 million on hospital admissions due to CVD conditions. 
The total expenditure for IHD patients was ฿2544 million and for stroke patients 
was ฿1920 million.  
Recommendation 
Future research should investigate health care expenditure from the patient’s 
perspective because CVD patients require long-time care. There are many hid-
den and out-of-pocket costs that occur with patients and their familybut few 
studies have been undertaken in Thailand. 
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